Bank of New York Mellon
OMIC

Bank of New York Mellon’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Bank of New York Mellon’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-851
Closed -$11.8K – 4348
2023
Q4 		$11.8K Hold
851
– – ﹤0.01% 4264
2023
Q3 		$9.73K Hold
851
– – ﹤0.01% 4298
2023
Q2 		$21.2K Sell
851
-4,778
-85% -$140K ﹤0.01% 4280
2023
Q1 		$204K Sell
5,629
-10
-0.2% -$613 ﹤0.01% 3912
2022
Q4 		$340K Buy
5,639
+654
+13% +$43.8K ﹤0.01% 3743
2022
Q3 		$374K Buy
4,985
+554
+13% +$57.9K ﹤0.01% 3733
2022
Q2 		$507K Sell
4,431
-300
-6% -$35.2K ﹤0.01% 3574
2022
Q1 		$895K Buy
4,731
+2,893
+157% +$669K ﹤0.01% 3378
2021
Q4 		$638K Buy
1,838
+133
+8% +$51.6K ﹤0.01% 3641
2021
Q3 		$572K Buy
1,705
+734
+76% +$376K ﹤0.01% 3734
2021
Q2 		$801K Buy
+971
New +$753K ﹤0.01% 3548

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Bank of New York Mellon's OMIC Position: Q1 2024 in Review

Bank of New York Mellon sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2024, closing a stake of 851 shares — an estimated $11.8K sold.

Bank of New York Mellon first reported a position in OMIC in Q2 2021 and held it in 11 quarters. The position peaked at $895K in Q1 2022. 42 funds tracked by Wall St. Rank hold OMIC as of Q1 2024.

  • Bank of New York Mellon reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 851 Singular Genomics Systems, Inc. Common Stock shares in Q1 2024, an estimated $11.8K.
  • Bank of New York Mellon first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2021 and held it in 11 quarters.
  • Bank of New York Mellon's Singular Genomics Systems, Inc. Common Stock position peaked at $895K in Q1 2022.
  • 42 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2024.

Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.